论文部分内容阅读
美国一项新的研究显示 ,一种新的基因检测方法诊断前列腺癌的敏感性为 97% ,特异性为 10 0 %。目前通常测定前列腺特异性抗原 (ＰＳＡ)血浓度来筛查前列腺癌 ,但非癌性前列腺疾病病人ＰＳＡ血浓度亦可升高。研究发现 ,前列腺癌过度表达α 甲基酚基辅酶Ａ消旋酶 (ＡＭＡＣＲ)。
A new study in the United States shows that a new genetic test has a sensitivity of 97% and a specificity of 100% for the diagnosis of prostate cancer. Prostate cancer is currently routinely measured by measuring PSA blood concentrations, but patients with non-cancerous prostate disease may also have elevated serum PSA levels. The study found that prostate cancer overexpression α-methylphenol-CoA racemase (AMACR).